Enhanced mucosal immune response in cattle persistently infected with foot-and-mouth disease virus. 2008

Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
Indian Veterinary Research Institute, Bangalore, Karnataka, India.

The mucosal immune response to foot-and-mouth disease virus (FMDV) type Asia 1 was examined in experimentally infected cattle by assaying antibodies by the virus-neutralizing test (VNT) and IgA ELISA in two secretory fluids, oesophageal pharyngeal fluid (OPF) and oro-nasal fluid (ONF). Out of 17 animals infected by the intradermo-lingual route, 12 became persistently infected (carriers), as defined by positive antigen capture RT-PCR reactions for FMDV RNA in OPF samples collected at 28 days or later after exposure. This proportion of carriers (71%) with FMDV Asia 1 is comparable to other serotypes of the virus. When the two groups were examined, the carriers and non-carriers showed no difference in the serum antibody titre until the end of the experiment at 182 days post-infection (DPI). However, despite an initial similarity significantly higher neutralizing antibody titres and FMDV-specific IgA response were detected among the carriers than the non-carriers in both of the secretory fluids. The response was higher and more stable in ONF compared to OPF. Thus, mucosal antibody assays have the potential to be used as a means of differentiating carrier from non-carrier cattle. Furthermore, the findings are consistent with the higher mucosal antibody response in carriers being an effect of persistent infection rather than the cause.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D008297 Male Males
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D010614 Pharynx A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx). Throat,Pharynxs,Throats
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002418 Cattle Diseases Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus. Bovine Diseases,Bovine Disease,Cattle Disease,Disease, Bovine,Disease, Cattle,Diseases, Bovine,Diseases, Cattle
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females

Related Publications

Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
July 1994, Research in veterinary science,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
April 1997, Epidemiology and infection,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
August 1985, Virology,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
July 2003, Virology,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
January 1989, Medicina,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
April 1969, The Cornell veterinarian,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
July 1978, American journal of veterinary research,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
December 1990, Virus research,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
January 2018, Frontiers in veterinary science,
Mohan S Maddur, and Maddur S Mohan, and Mukund R Gajendragad, and Subodh Kishore, and Ashok K Chockalingam, and V V S Suryanarayana, and S Gopalakrishna, and Nem Singh
September 1971, Journal of dairy science,
Copied contents to your clipboard!